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Abstract
Background: Accurate and timely regional data on smoking trends allow tobacco control interventions to be
targeted at the areas most in need and facilitate the evaluation of such interventions. Electronic primary care
databases have the potential to provide a valuable source of such data due to their size, continuity and the
availability of socio-demographic data. UK electronic primary care data on smoking prevalence from The Health
Improvement Network (THIN) have previously been validated at the national level, but may be less representative
at the regional level due to reduced sample sizes. We investigated whether this database provides valid regional
data and whether it can be used to compare smoking prevalence in different UK regions.
Methods: Annual estimates of smoking prevalence by government office region (GOR) from THIN were compared
with estimates of smoking prevalence from the General Lifestyle Survey (GLF) from 2000 to 2008.
Results: For all regions, THIN prevalence data were generally found to be highly comparable with GLF data from
2006 onwards.
Conclusions: THIN primary care data could be used to monitor regional smoking prevalence and highlight
regional differences in smoking in the UK.
Background
Robust regional data on smoking prevalence are impor-
tant for monitoring regional trends in smoking and eval-
uating the impact of national and regional tobacco
control interventions. Currently, few large-scale high-
quality regional data on smoking prevalence in the UK
are available. The main source of regional prevalence
data in the United Kingdom (UK) is national survey
data. The General Lifestyle Survey (GLF), the current
‘gold standard’ for measuring smoking prevalence in
Great Britain, has highlighted significant variation in
smoking prevalence across the British regions [1]. How-
e v e r ,s u r v e yd a t at e n dt ob ei n f r e q u e n t l yc o l l e c t e do r
have small sample sizes, particularly at the regional
level, and there is often a significant time lag between
the collection and the release of the data [2,3]. Electro-
nic primary care databases have the potential to provide
av a l u a b l es o u r c eo fr e g i o n a ld a t ao ns m o k i n gp r e v a -
lence due to their size, availability of monthly data and
continuity.
The Health Improvement Network (THIN) (http://
csdmruk.cegedim.com/) is a database of UK electronic
p r i m a r yc a r er e c o r d s .T h ev a l i d i t yo fT H I Nd a t ah a s
been demonstrated for major events [4-9]. More
recently, THIN data on smoking status have been vali-
dated at the national level. From 2006 onwards there
was, despite the very different methods of obtaining pre-
valence estimates between the two data sources, gener-
ally good agreement between the prevalence of current
smoking recorded in THIN and smoking rates based on
national survey data from the GLF, suggesting that
THIN may be an accurate means of monitoring smok-
ing prevalence nationally [10]. However, the validity of
THIN data on smoking prevalence at the regional level,
which may be less precise as a result of smaller sample
sizes and reduced representativeness, has yet to be
demonstrated.
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estimates of regional smoking prevalence from THIN
with those from the GLF to assess whether THIN data
can be used to monitor regional variation and trends in
smoking prevalence.
Methods
The version of THIN used in this study contains the
primary care records of approximately 8 million patients
from 446 general practices in England, Scotland, Wales
and Northern Ireland, of whom 3.2 million are currently
registered with a practice and can be followed prospec-
tively; retrospective data is available for the remaining
patients who have since either died or transferred from
THIN practices. Prospective medical records are
recorded using the Vision general practice computer
system software, and serve as the primary medical
record for the practice. GPs are able to record diag-
noses, demographic information, lifestyle characteristics
(such as smoking status) and other medical information.
The dataset represents approximately 6% of the UK
population [11].
Currently, the main source of statistics for monitoring
smoking prevalence in Britain is a national, annual sur-
vey, the GLF [12], formerly known as the General
Household Survey (GHS). It collects information on a
range of topics from around 16,000 adults aged 16+ liv-
ing in private households in England, Wales and Scot-
land each year. Topics include housing, employment,
health, alcohol consumption and income as well as
smoking, and data are available by age and sex. It uses a
probability, stratified two-stage sample design and aims
to interview all adults aged 16 or over at each sampled
address [13]. In 2009 the response rate was 73% [1]. For
this study, we used the GLF’s measure of the prevalence
of current cigarette smoking, which is obtained by ask-
ing respondents ‘do you smoke cigarettes at all nowa-
days’. The data were weighted for non-response and
also weighted to the population distribution of region,
age group and sex.
The GLF covers England, Wales and Scotland only;
therefore, the validation of the regional THIN preva-
lence data did not include data from Northern Ireland.
The GLF surveys people aged 16 and over only and
therefore under 16s were also excluded from this study.
GLF data from 2000 to 2008, stratified by government
office region (GOR), were used in this study.
For each year from 2000 to 2009 all live patients who
were over the age of 16 and registered with a practice
on an index date of 1st July of that year were identified
from the THIN dataset and stratified by region. THIN
data are regionally stratified by Strategic Health Author-
ity (SHA). SHAs are coterminous with GORs, except
that the South East region is divided into two: South
Central and South East Coast. The THIN data for these
two SHA regions were therefore combined. Patients
who registered with a practice within the previous three
months were excluded from this analysis (the GP con-
tract requires that the smoking status of newly-register-
ing patients is recorded within three months for this
recording to be financially rewarded). The prevalence of
smoking each year was calculated from the data
recorded in medical records. All records of smoking sta-
tus, identified by relevant Read Codes (a hierarchical
dictionary of medical nomenclature [14]), entered into a
patient’s notes on or after their registration date were
extracted. Patients were classified as current smokers at
a given index date if their most recent smoking-related
entry in their medical records prior to this index date
identified them as such. The percentage of patients with
no smoking status recorded decreased during the study
period, from 36% in 2000 to 10% in 2009. A previous
study has shown that the majority of patients with miss-
ing smoking records in THIN are ex or non-smokers,
and therefore all patients with no smoking formation
were assumed not to be current smokers at that point
in time [15].
The way in which estimates of smoking prevalence are
obtained are clearly very different in THIN and the
GLF; however, the previous validation of THIN smoking
prevalence data also used the GLF as a comparator and
found that the estimates were comparable from 2006,
suggesting that it is appropriate to compare these two
data sources [10].
The sampling method of the GLF is designed to pro-
duce regionally representative estimates of smoking
prevalence [13]. However, THIN comprises those GP
practices in each region that have agreed to contribute
their data to the database, and may not be regionally
representative. We therefore initially compared the
demographic structure of THIN at the regional level
with regional population estimates from the Office of
National Statistics [16]. We found THIN to be highly
representative in terms of age and sex structure at the
regional level. Population pyramids showing the repre-
sentativeness of THIN by age and sex on a regional
basis are presented as supplementary material (Addi-
tional file 1). Since both GLF and THIN are regionally
representative, the prevalence of smoking was com-
pared between these two data sources directly, without
standardisation for age or sex. To ensure that this
assumption was appropriate, we also calculated age
and sex-standardised estimates, calculated through
indirect standardisation by applying age- and sex-spe-
cific smoking rates from the corresponding GLF data
to the THIN population. These are extremely similar
to the unstandardised estimates and are shown in addi-
tional file 2.
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ent regions based on THIN were compared graphically
with point estimates, and confidence intervals around
those estimates, from the GLF, to assess whether regio-
nal estimates of prevalence in THIN are similar to those
from the GLF. Confidence intervals were not drawn for
THIN as its much larger sample size results in precise
estimates and very narrow confidence intervals which
are not easily graphically distinguishable from the point
estimates. These confidence intervals are shown in addi-
tional file 3.
The data used in this study form part of the recently-
developed Nottingham Tobacco Control Database, a
compilation of sources of smoking-related information
at a national and regional level. All analysis was carried
out in Stata Version 11.0 (Stata Corp, College Station,
T X )a n dt h ea n a l y s i so fT H I Nd a t af o rt h i ss t u d yw a s
approved by the Derbyshire Research Ethics Committee.
Results
T a b l e1b e l o ws h o w st h es a m p l es i z e so ft h eG L Fa n d
THIN by region in 2000 and 2008, demonstrating the
much-reduced sample sizes in the regional data. The
regional sample sizes in THIN remain extremely large,
with over 100,000 people in each region in 2008. The
regional GLF sample sizes are much smaller, ranging
from 642 in the North East region to 2,082 in the South
East in 2008.
Figure 1 shows the comparison of THIN and GLF
smoking prevalence data by region from 2000 to 2008.
The GLF data show the general decreasing trend in
smoking prevalence in recent years in all regions. In
most regions, prevalence estimates from THIN con-
verged with those from the GLF over the years of the
study, with good agreement between the data sources,
and THIN estimates falling within the confidence inter-
vals of the GLF, from 2006 onwards.
In three regions this convergence is not observed. The
data from the West Midlands did not converge during
the study period, although the discrepancy between the
two datasets fell, and the THIN estimate was within the
confidence interval for the GLF estimate in the final
year. The Yorkshire and Humber data converged during
the study period but the 2008 THIN estimate did not
fall within the GLF confidence interval. The data from
Wales converged from 2001 to 2005, at which point
prevalence as measured by both data sources was
approximately 22%. In subsequent years the values
moved apart again; however, the THIN estimates were
within the confidence interval for the GLF in the final
two years of the study.
Discussion
To our knowledge, this is the first study to validate pri-
mary care smoking data at the regional level. These
results show that estimates of regional smoking preva-
lence from THIN are highly comparable to the corre-
sponding estimates from the current main source of
such data. In most regions, smoking prevalence based
on THIN data was similar to that found by the GLF
from 2006 onwards. Primary care data could therefore
be used to help target tobacco control initiatives at the
areas with the highest smoking prevalence and to moni-
tor prevalence across regions.
The main limitation of our study is that we were
unable to compare THIN data with the corresponding
data for all of the UK’s regions. The GLF covers Great
Britain only, and therefore we could not validate preva-
l e n c ed a t af o rN o r t h e r nI r e l and. However, our results
were generally consistent across all regions that were
included, and it is likely that THIN smoking prevalence
estimates for Northern Ireland are similarly accurate.
Further to this, we were unable to explore the compar-
ability of THIN and GLF prevalence estimates beyond
2008. Estimates from these two data sources were simi-
lar in the final three years of the study only; further
research will be required in the future to ascertain
whether this agreement is maintained in subsequent
years.
A further limitation of our study is that the GLF and
THIN may underestimate smoking prevalence, as both
GLF respondents and general practice patients do not
have their smoking status biochemically validated. How-
ever, the high costs associated with such validation
mean that it is extremely difficult to obtain it for such
large samples. In addition, because there is considerable
variation in the completeness of recording between UK
general practices, these results are not necessarily gener-
alisable across all practices.
Table 1 Sample sizes of General Lifestyle Survey and
THIN, 2000 and 2008
GLF 2000 THIN 2000 GLF 2008 THIN 2008
North East 686 99,054 642 109,322
North West 1,701 286,949 1,691 316,195
Yorks And Humber 1,253 136,982 1,370 144,646
East Midlands 997 130,418 1,222 140,882
West Midlands 1,300 285,633 1,354 317,585
East Of England 1,348 222,265 1,497 243,355
London 1,504 293,421 1,207 338,859
South East 2,062 525,110 2,082 704,886
South West 1,303 290,763 1,420 350,742
Wales 724 141,372 830 210,585
Scotland 1,211 198,045 1,304 250,109
Total 14,089 2,703,864 14,619 3,245,031
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diminished sample sizes of the GLF at the regional level
mean that there may be significant error in its estimates.
However, during the study period the GLF was the lar-
gest survey providing regional prevalence data for Great
Britain, and we believe that this is therefore the most
appropriate comparator.
Despite the diminished sample size of the THIN data
at the regional level, the results of this study are broadly
consistent with those of the previous validation study of
these data carried out at the national level. As at the
national level, prevalence estimates based on THIN
from most regions were found to be similar to those
based on the GLF from 2006 [10].
The convergence in prevalence estimates from THIN
and the GLF is almost certainly a result of the voluntary,
pay-for-performance general practice contract intro-
duced in 2004 [17]. The contract requires GPs to record
their patients’ smoking status at least every 27 months
(every 15 months for patients with specified chronic dis-
eases) and has been taken up by almost all GPs [18].
Convergence between the two datasets by 2006 was
not observed in all regions; there was greater discre-
pancy between the data sources for the West Midlands,
Y o r k s h i r ea n dt h eH u m b e ra n dW a l e s .R e g i o n a lG L F
data are based on small sample sizes, with resultant
higher sampling error, as demonstrated by the wide con-
fidence intervals, and any discrepancy between THIN
and GLF estimates may reflect uncertainty associated
with the GLF data rather than inadequacy of estimates
from THIN. Further to this, while we were able to con-
firm that THIN is representative regionally in terms of
age and sex, we have not assessed representativeness in
terms of other factors such as social class. This may also
account for some of the discrepancy in the three afore-
mentioned regions. That even in these regions, the
THIN estimates in two of the final three years (York-
shire and Humber), the final year (West Midlands) and
the final two years (Wales) of the study were within the
confidence intervals of the GLF estimates demonstrates
that estimates from GLF and THIN for these regions
may indeed be comparable. The discrepancy in the final
Figure 1 Smoking prevalence by region from THIN and GLF (2000-2008). Solid line: GLF Dashed line: THIN
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young adults being underrepresented in the THIN
population of this region in the final year of the study
(as shown in additional file 1).
There are several advantages to using THIN preva-
l e n c ed a t ac o m p a r e dw i t ht h en a t i o n a ls u r v e yd a t a .
THIN data are routinely collected, are released 3-4
times per year, and have a lag of only 3-8 months before
data become available [10]. A further advantage is its
size; the standard error of THIN’s smoking prevalence
estimates is significantly smaller than those of the GLF
at a national level [10]. At a regional level, GLF esti-
m a t e sa r ep r o n et om o r ee r r o rd u et om u c hr e d u c e d
sample sizes and confidence intervals are so wide, as
demonstrated in Figure 1, that changes from year to
year will be difficult to detect; therefore the large sample
size in THIN is extremely valuable. Further to this,
THIN provides monthly data, which is particularly use-
ful in the evaluation of short term impacts of tobacco
control initiatives.
Based on the THIN data, it was found that in 2008
Scotland (24%), the North West (23.5%), and Northern
Ireland (23.5%) had the highest smoking prevalence in
the UK. The East of England (19%), the West Midlands
(19%) and South East England (19%) had the lowest
prevalence. There remains substantial variation in
smoking prevalence between the regions, with higher
prevalence often being observed in regions with the
lowest per capita disposable income [19]. Smoking is
an important contributor to health inequalities [20,21].
Therefore, reducing regional differences in smoking
prevalence will contribute to alleviating health inequal-
ities in the UK. This study indicates that THIN may be
au s e f u ls o u r c eo fd a t af o rm o n i t o r i n gt h e s er e g i o n a l
differences.
To our knowledge, the current study and that by Szat-
kowski et al. are the first to explore the possibility of
using primary care data to monitor smoking prevalence
[2]; our results indicate that primary care data are a
potentially valuable source of such information. Previous
research suggests that surveys which monitor smoking
prevalence in EU Member States often have small sam-
ple sizes and are irregularly carried out [22]. This sug-
gests that the way in which smoking prevalence is
monitored internationally has similar limitations to the
way it is currently monitored in Britain. Future research
exploring the possibility of using primary care data to
monitor smoking prevalence in countries other than
Britain may therefore be warranted.
Conclusions
It is important to monitor regional patterns of smoking
prevalence to ensure tobacco control measures in the
UK are targeted at the areas most in need and help to
reduce the health inequality caused by smoking. THIN
data on smoking prevalence at the regional level are
comparable with the main source of UK data on this
measure, and could therefore be used to monitor longi-
tudinal regional trends in smoking prevalence.
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